logo
Malaysian medics ‘a cheap yet quality asset' in Singapore

Malaysian medics ‘a cheap yet quality asset' in Singapore

Malaysian doctors are highly sought after in Singapore, says a doctor working there.
PETALING JAYA : Malaysian medical graduates are highly sought after by hospitals in Singapore, which consider them to be 'cheap yet high quality assets', according to a Malaysian doctor serving in the city-state.
Wanting to only be known as Dr Akram, the doctor said Malaysia's holistic system of housemanship made Malaysian medical graduates among the top choices for Singapore hospitals.
'At the hospital where I work, 40% of medical officers are graduates of top universities in Malaysia,' said Akram, who has been working in Singapore for a year now, after serving six months as a medical officer at a Malaysian hospital.
Singapore has 11 public hospitals, nine private hospitals, and 10 specialist centres for specific diseases. 'Singapore wants to build two new hospitals, so I'm sure more Malaysian medical graduates or medical officers will be recruited,' said Akram.
He said colleagues had informed him that many Malaysian medical officers had plans to work overseas, drawn by higher salaries and better benefits, as well as improved work-life balance in line with their responsibilities and workload.
'Many medical students from two popular local universities are already eyeing opportunities and are keen to join us here,' he added.
A news report in March quoted Marina Mat Baki, dean of Universiti Kebangsaan Malaysia's medical faculty, as saying that 30 graduates moved to Singapore in 2023, 25 in 2022, 15 in 2021, and just two in 2020.
Akram said Malaysia's system provided adequate training and exposure, but many medical officers suffer from burnout due to poor treatment, lack of welfare support, and the absence of work-life balance.
'Worse still, there seems to be no end in sight to these issues,' he said.
He said junior medical officers in Singapore received monthly allowances which also covered housing and 'personal wellbeing', as well as performance and corporate variable bonuses, on top of their regular salaries and on-call compensation.
They are also entitled to annual leave, sick leave, non-medical leave, marriage leave, family care leave, training leave, and birthday leave.
Akram added that applying for leave in Singapore was much easier than in Malaysia, where there is a frequent staff shortage.
The number of patients treated in a day was significantly lower in Singapore. 'Here, a medical officer typically sees only 20 patients a day, while in Malaysia, one doctor may have to treat up to 40 patients daily,' Akram said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Private Healthcare Sector Faces Rising Medical Inflation Pressures, CIMB
Private Healthcare Sector Faces Rising Medical Inflation Pressures, CIMB

BusinessToday

time6 hours ago

  • BusinessToday

Private Healthcare Sector Faces Rising Medical Inflation Pressures, CIMB

Malaysia's private healthcare sector is grappling with rising medical inflation and potential structural changes as discussions advance on the adoption of a diagnosis-related group (DRG)–based hospital payment system, according to insights from a recent meeting between CIMB Securities and Datuk Dr Kuljit Singh, President of the Association of Private Hospitals Malaysia (APHM). Private hospitals currently cater to about 30% of Malaysia's patient load—funded primarily through self-payment, personal insurance, and employee benefits—while the public sector supports the remaining 70%. Dr Kuljit highlighted that Malaysia's healthcare quality remains on par with, or better than, many ASEAN peers, sustaining the nation's appeal as a medical tourism hub. Medical Inflation Above Global Average Bank Negara Malaysia (BNM) data shows that medical inflation hit 15% in 2024, surpassing the global average of 10% and the Asia-Pacific average of 11%. Key cost drivers include the adoption of advanced medical technologies, rising medical supply costs, manpower shortages, and overall inflationary pressures. Between 2021 and 2023, claims in the Medical and Health Insurance/Takaful (MHIT) segment surged 73%, outstripping the 21% growth in premiums. Claim frequency more than doubled to 25 per 100 policyholders in 2023 from 11 in 2018. In response, BNM has capped annual premium increases at 10% until the end of 2026, with hikes staggered over three years. Dr Kuljit cautioned that prolonged premium caps could prompt insurers to tighten reimbursement terms and limit hospital or treatment options, potentially curbing investment in private healthcare. To mitigate rising claims, private hospitals are offering negotiated discounts to insurers, which in turn lower out-of-pocket costs for insured patients compared with self-paying patients. Exploring DRG to Curb Costs The proposed DRG system would replace the traditional fee-for-service model with fixed prices for treatments based on case complexity and industry benchmarks. APHM is working with the Ministry of Health to collect and standardise data for a private healthcare DRG database. However, implementation challenges remain due to the lack of a universal healthcare financing framework and comprehensive private-sector data. Globally, DRG models are largely confined to public healthcare systems, with limited adoption in private healthcare. Dr Kuljit noted that complications or additional care beyond the DRG package often create billing and coverage issues in private settings. Sector Outlook CIMB Securities noted that KPJ Healthcare Bhd could be more exposed to DRG-related risks, with 98.1% of its revenue derived locally in 1Q25, compared with IHH Healthcare Bhd's 18–21% Malaysian revenue contribution. The brokerage maintains an Overweight stance on Malaysia's healthcare sector, citing its defensive nature, resilient demand, organic expansion, and favourable demographics. IHH remains its top pick with a Buy rating and a target price of RM8.50, trading at attractive valuations relative to historical and regional averages. KPJ is rated Hold with a TP of RM2.90, as its current share price is seen to have priced in recent operational improvements.

Still not safe to eat: Port Dickson mussels remain off-limits, biotoxin levels too high
Still not safe to eat: Port Dickson mussels remain off-limits, biotoxin levels too high

Malay Mail

time11 hours ago

  • Malay Mail

Still not safe to eat: Port Dickson mussels remain off-limits, biotoxin levels too high

SEREMBAN, Aug 15 — Laboratory tests on the second sample conducted by the Kuala Lumpur Fisheries Biosecurity Centre (PBPKL) on Tuesday on mussels and shellfish in Port Dickson waters found that the biotoxin reading was still above 800 parts per billion (ppb). Negeri Sembilan Fisheries Department (JPNS) director Kasim Tawe said therefore the seafood is still unsafe as it could cause health problems and the ban on eating it is still in force. 'For the samples we took on Tuesday at two locations, namely in the waters of Kampung Teluk and Sungai Sekawang, the biotoxin readings were still above the limit. The third sample will be taken next week. 'As the results of the second sample still exceed the permitted level, JPNS will take samples and monitor the situation every week until the results of the biotoxin level are lower than the permitted level,' he told Bernama here today. In this regard, he once again reminded the public not to collect, take or harvest shellfish in the waters for a while. Earlier, the Telok Kemang Area Fishermen's Association claimed to have detected a phenomenon believed to be an algal bloom in Pasir Panjang waters and issued an announcement banning the sale and harvesting of shellfish (dwicengkerang) from the waters of Port Dickson. — Bernama

Medical insurance overhaul in progress, says BNM, with new plans set for 2026
Medical insurance overhaul in progress, says BNM, with new plans set for 2026

Malay Mail

time11 hours ago

  • Malay Mail

Medical insurance overhaul in progress, says BNM, with new plans set for 2026

KUALA LUMPUR, Aug 15 — Interim measures to manage rising medical costs remain effective, as ongoing initiatives will strengthen healthcare delivery and help curb medical insurance inflation, said Bank Negara Malaysia (BNM) Governor Datuk Seri Abdul Rasheed Ghaffour. He said that over the past three years, the government has implemented five key thrusts and 11 recommendations aimed at improving medical services, enhancing implementation, and addressing the rising cost of health insurance premiums. 'For example, we are revamping the medical and health insurance/takaful (MHIT) product. You may be able to see the base product. We are testing it as we go,' he told a press conference after announcing Malaysia's second-quarter 2025 gross domestic product (GDP) performance here today. The MHIT revamp involves a redesigned base product, to be completed by year-end and rolled out in selected areas next year. Abdul Rasheed said other initiatives involve strengthening the digital health system, expanding cost-effective healthcare options, leveraging primary care providers to reduce implementation costs, and transforming the primary care payment mechanism through digital tools. 'These efforts are expected to bring down payment costs and ensure a more sustainable healthcare system,' he added. Last December, BNM announced interim measures with the insurance and takaful industry to help policyholders facing premium revisions for their MHIT products, aimed at easing their immediate financial burden while preserving coverage. — Bernama

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store